Microsatellite alterations at 5q21, 11p13, and 11p15.5 Do not predict survival in non-small cell lung cancer

Clinical Cancer Research

Volumn 3, Issue 7, 1997, Pages 1229-1235

  Sánchez Céspedes, Montserrat ^a   Rosell, Rafael ^a   Pifarré, Alex ^a   López Cabrerizo, Maria Paz ^a   Barnadas, Agustí ^a   Sánchez, José Javier ^b   Lorenzo, Juan Carlos ^a   Abad, Albert ^a   Monzó, Mariano ^a   Navas Palacios, José J ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CHROMOSOME 11P; CHROMOSOME 5P; FEMALE; GENE DELETION; GENE LOCATION; GENETIC MARKER; HETEROZYGOSITY LOSS; HUMAN; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 1842365448     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Vioque, J., and Bolumar, F. Trends in mortality from lung cancer in Spain, 1952-1987. J. Epidemiol. Community Health, 41: 74-78, 1987.
2. Carbone, D. P., and Minna, J. D. The molecular genetics of lung cancer. Adv. Intern. Med., 37: 153-171, 1992.
3. Rosell, R., Monzó, M., Pifarré, A., Ariza, A., Sánchez, J. J., Moreno, I., Maurel, J., López, M. P., Abad, A., and de Anta, J. M. Molecular staging of non-small cell lung cancer according to K-ras genotypes. Clin. Cancer Res., 2: 1083-1086, 1996.
4. Carbone, D. P., Mitsudomi, T., Chiba, I., Piantadosi, S., Rusch, V., Nowak, J. A., McIntire, D., Slamon, D., Gazdar, A., and Minna, J. p53 inmunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer. Chest. 106: 377S-381S, 1994.
5. neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res., 50: 5184-5191, 1990.
6. Mitsudomi, T., Oyama, T., Nishida, K., Ogami, A., Osaki, T., Sugio, K., Yasumoto, K., Sugimachi, K., and Gazdar, A. K. Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication. Clin. Cancer Res., 2: 1185-1189, 1996.
7. Tsuchiya, E., Nakamura, Y., Weng, S-Y., Nakagawa, K., Tsuchiya, S., Sugano, H., and Kitagawa, T. Allelotype of non-small cell lung carcinoma. Comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res., 52: 2478-2481, 1992.
8. Hosoe, S., Ueno, K., Shigedo, Y., Tachibana, I., Osaki, T., Kumagai, T., Tanio, Y., Kawase, I., Nakamura, Y., and Kishimoto, T. A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung. Cancer Res., 54: 1787-1790, 1994.
9. Ashton-Rickardt, P. G., Wyllie, A. H., Bird, C. C., Dunlop, M. G., Steel, C. M., Morris, R. G., Piris, J., Romanowski, P., Wood, R., White, R., and Nakamura, Y. MCC, a candidate familial polyposis gene in 5q21, shows frequent allele loss in colorectal and lung cancer. Oncogene, 6: 1881-1886, 1991.
10. Kinzler, K. W., Nilbert, M. C., Vogelstein, B., Bryan, T. M., Levy D. B., Smith, K. J., Preisinger, A. C., Hedge, P., Markham, A., Carlson, M., Joslyn, G., Groden, J., White, R., Miki, Y., Miyoshi, Y., Nishisho, I., and Nakamura, Y. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science (Washington DC), 251: 1366-1370, 1991.
11. Kinzler, K. W., Nilbert, M. C., Su, L. K., Vogelstein, B., Bryan, T. M., Levy, D. B., Smith, K. J., Preisinger, A. C., Hedge, P., McKechnie, D., Finniear, R., Markham, A., Groden, J., Boguski, M. S., Altschul, S. F., Horii, A., Ando, H., Miyoshi, Y., Miki, Y., Nishisho, I., and Nakamura, Y. Identification of FAP locus genes from chromosomes 5q21. Science (Washington DC), 253: 661-665, 1991.
12. Cho, K. R., and Vogelstein, B. Genetic alterations in the adenoma carcinoma sequence. Cancer (Phila.), 70: 1727-1731, 1992.
13. Boynton, R. F., Blount, P. L., Yin, J., Brown, V. L., Huang, Y., Tong, Y., McDaniel, T., Newkirk, C., Resau, J. H., Raskind, W. H., Haggit, R. C., Reid, B. J., and Meltzer, S. J. Loss of heterozygosity involving the apc loci occurs in the majority of human esophageal cancers. Proc. Natl. Acad. Sci. USA, 89: 3385-3388, 1992.
14. Fong, M. K., Zimmerman, P. V., and Smith, P. J. Tumor progression and loss of heterozygosity at 5q and 18q in non-small cell lung cancer. Cancer Res., 55: 220-223, 1995.
15. Gessler, M., Poustka, A., Cavenee, W., Neve, R. R., Orkin, S. H., and Bruns, G. A. P. Homozygous deletion in Wilms' tumours of a zinc-finger gene identified by chromosome jumping. Nature (Lond.), 343: 774-778, 1990.
16. Weinberg, R. A. Tumor suppressor genes. Science (Washington DC), 254: 1138-1146, 1991.
17. Winqvist, R., Mannermaa, A., Martti, A., Blanco, G., Taskinen, P. J., Kiviniemi, H., Newsham, I., and Cavenee, W. Refinement of regional loss of heterozygosity for chromosome 11p15.5 in human breast tumors. Cancer Res., 53: 4486-4488, 1993.
18. Cheng, J. Q., Crepin, M., and Hamelin, R. Allelic losses on chromosome 1p, 3p, 11p, and 11q in human non-small cell lung cancers. C. R. Acad. Sci., 311: 175-180, 1990.
19. Ludwig, C. U., Raeffle, G., Dalquen, P., Stulz, R., and Obrecht, J. P. Allelic loss on the short arm of chromosome 11 in non-small cell lung cancer. Int. J. Cancer, 49: 661-665, 1992.
20. Fong, M. K., Zimmerman, P. V., and Smith, P. J. Correlation of loss of heterozygosity at 11p with tumour progression and survival in non-small cell lung cancer. Genes Chromosomes & Cancer, 10: 183-189, 1994.
21. Bepler, G., and Garcia-Blanco, M. Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletions mapping in human non-small cell lung cancer. Proc. Natl. Acad. Sci. USA, 91: 5513-5517, 1994.
22. Skinner, M. A., Vollmer, R., Huper, G., Abbot, P., and Iglehart, J. D. Loss of heterozygosity for genes on 11p and the clinical course of patients with lung carcinoma. Cancer Res., 50: 2303-2306, 1990.
23. Sidransky, D. Is human patched the gatekeeper of common skin cancers? Nat. Genet., 14: 7-8, 1996.
24. Phelan, C. M., Rebbeck, T. R., Weber, B. L., Devilee, P., Ruttledge, M. H., Lynch, H. T., Lenoir, G. M., Stratton, M. R., Easton, D. F. Ponder, B. A., Cannon-Albright, L., Larsson, C., Golgar, D. E., and Narod, S. A. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nat. Genet., 12: 309-311, 1996.
25. KIP2, on chromosome 11p15. Proc. Natl. Acad. Sci. USA, 93: 3026-3030, 1996.
26. KIP2 is mutated in Beckwith-Wiedemann syndrome. Nat. Genet., 14: 171-173, 1996.
27. De Bustros, A., Nelkin, B. D., Silverman, A., Ehrlich, G., Poiesz, B., and Baylin, S. B. The short arm of chromosome 11 is a hot spot for methylation in human neoplasia. Proc. Natl. Acad. Sci. USA, 85: 5693-5697, 1988.
28. Mountain, C. F. A new international staging system for lung cancer. Chest, 89: 225S-232S, 1986.
29. McPherson, M. J., Quirke, P., and Taylor, G. R. Extraction of DNA from archival material. In: D. Rickwood and B. D. Hames (eds). PCR: A Practical Approach, pp. 33-40. New York: Oxford University Press, 1991.
30. Kaplan, E., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
31. Miller, R. G., Jr. Survival Analysis, pp. 44-102. New York: John Wiley & Sons, Inc., 1981.
32. Cox, D. R. Regression models and life-tables. J. R. Stat. Soc. B, 34: 187-220, 1972.
33. Wieland, I., Bohn, M., Arden, K. C., Ammermüler, T., Bogatz, S., Viars, C. S., and Rajewsky, M. F. Allelic deletion mapping on chromosome 5 in human lung cancer. Oncogene, 12: 97-102, 1996.
34. Su, L-K., Vogelstein, B., and Kinzler, K. W. Association of the APC tumor suppressor protein with catenins. Science (Washington DC), 262: 1667-1668, 1993.
35. Horii, A., Nakatsuru, S., Miyoshi, Y., Ichii, S., Nagase, H., Ando, H., Yanagisawa, A., Tsuchiya, E., Kato, Y., and Nakamura, Y. Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res., 52: 6696-6698, 1992.
36. Knudson, A. G. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA, 68: 820-823, 1971.
37. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor gene p16/CDKN2/MTS1 in human cancer. Nat. Med., 1: 686-692, 1995.
38. Tran, K. Y., and Newsham, I. F. High density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas. Cancer Res., 56: 2916-2921, 1996.
39. O'Briant, K., and Bepler, G. Definition of the lung cancer region on centromeric chromosome 11p15.5 within 250 kb. Proc. Am. Assoc. Cancer Res., 37: 552, 1996.
40. Iizuka, M., Sugiyama, Y., Shiraishi, M., Jones, C., and Sekiya, T. Allelic losses in human chromosome 11 in lung cancer. Genes Chromosomes & Cancer, 13: 40-46, 1995.
41. Kondo, M., Suzuki, H., Ueda, R., Osada, H., Takagi, K., Takahashi, T., and Takahashi, T. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene, 10: 1193-1198, 1995.
42. KIP2 genes at 11p15.5. Oncogene, 12: 1365-1368, 1996.
43. Chan, A. S. K., Lam, W. K., Wong, M. P., Fu, K. H., Lee, J., Yew, W., Chin, S. W., and Lung, M. L. Chromosomal 11 alterations in non-small cell lung cancer carcinomas in Hong Kong. Lung Cancer, 15: 51-65, 1996.